1. Home
  2. SUPN vs INFQ Comparison

SUPN vs INFQ Comparison

Compare SUPN & INFQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

N/A

Current Price

$29.57

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Logo Infleqtion Inc. Common Stock

INFQ

Infleqtion Inc. Common Stock

N/A

Current Price

$8.59

Market Cap

2.1B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
SUPN
INFQ
Founded
2005
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2014
2025

Fundamental Metrics

Financial Performance
Metric
SUPN
INFQ
Price
$29.57
$8.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
7
Target Price
★ $54.14
$19.57
AVG Volume (30 Days)
2.4M
★ 5.7M
Earning Date
10-29-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 8100.00
N/A
EPS
★ 2.78
N/A
Revenue
★ $1,239,000,000.00
N/A
Revenue This Year
$51.56
$38.99
Revenue Next Year
$30.35
$23.63
P/E Ratio
$10.65
★ N/A
Revenue Growth
★ 4.29
N/A
52 Week Low
$25.92
$7.01
52 Week High
$59.68
$21.28

Technical Indicators

Market Signals
Indicator
SUPN
INFQ
Relative Strength Index (RSI) 31.65 41.91
Support Level $25.92 $7.01
Resistance Level $51.59 $9.84
Average True Range (ATR) 2.00 0.70
MACD -0.52 0.15
Stochastic Oscillator 19.96 52.30

Price Performance

Historical Comparison
SUPN
INFQ

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About INFQ Infleqtion Inc. Common Stock

Infleqtion Inc developing and commercializing quantum technology products as part of a full-stack platform, which currently includes offerings such as quantum sensing, quantum computing, and software. Its quantum-enabled solutions are focused on addressing the world's pressing challenges, with technologies actively deployed across some sectors today, including defense and security, artificial intelligence (AI), energy optimization, space and frontier, materials discovery, and cybersecurity.

Share on Social Networks: